|
|
Other links at Articles > Business of Medicine |
| 1. |
Genzyme Recalls Three Transplant Drug Lots: U.S. FDA
|
|
|
Genzyme Corp has voluntarily recalled three lots of Thymoglobulin, its injectable drug for transplant patients, after one lot failed a stability test, the U.S. Food and Drug Administration said on Thursday. Reuters Health Information
|
| 2. |
Tenet to Sell Broadlane Stake, Proceeds $155 Mln
|
|
|
Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million. Reuters Health Information
|
| 3. |
Cancer Stars in US Television Broadcast Tonight
|
|
|
Three major television networks in the United States will be airing an hour-long program about cancer tonight, with celebrities raising awareness about the disease and appealing to the public for donations to cancer research. Medscape Medical News
|
| 4. |
Merck Reaches Settlement in Medicaid Rebate Probe
|
|
|
Merck & Co agreed to pay more than $649 million to resolve litigation related to its cholesterol drug Zocor and painkiller Vioxx, a federal prosecutor said on Thursday. Reuters Health Information
|
|
|
